InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Demetri George, Director. Officer active across 1 company, notably Blueprint Medicines Corp. In total, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €702. Activity tracked since 2 June 2021. The latest transaction was filed on 13 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
10 shares@ US$82.66100.0% of flowCommon StockSEC:0001415889-22-007129:0
Ideal exit: 9 Apr 2022 (T+270)
2,250 shares0Common StockSEC:0001179110-21-006418:0
2,250 shares0Common StockSEC:0001179110-21-006418
3 of 3 declarations
About Demetri George
Demetri George is a Board Member at Blueprint Medicines Corp. He plays a vital role in the governance of the company, providing strategic advice and overseeing development initiatives.
